Sanofi awards Healthy Futures Solution Fund grants to advance community-led solutions, expand equitable access to care across Massachusetts

26.06.25 14:00 Uhr

Werte in diesem Artikel

  • New fund supports nonprofit partners working to address social drivers of health and strengthen community well-being

CAMBRIDGE, Mass., June 26, 2025 /PRNewswire/ -- Sanofi today announced it has awarded over $1 million in grants through its inaugural Healthy Futures Solution Fund to support local nonprofits across Massachusetts that are advancing community-led solutions to improve health and well-being in historically undersupported communities. The initiative is part of Sanofi's broader commitment to improve equitable access to healthcare by addressing structural factors, such as lack of access to housing, food, and behavioral health.

Launched earlier this year, the Fund strategically invests in nonprofit partners with deep roots in the communities they serve. Selected from Sanofi's existing network of Massachusetts-based partners, the grantees will use the funding over the next year to scale programs that address root causes of health disparities while delivering measurable impact for historically undersupported populations.

Deborah Glasser
Head, Specialty Care North America and US Country Lead, Sanofi
"Sanofi believes that the most sustainable health solutions are created by and for the communities closest to the challenges. Through the Healthy Futures Solution Fund, we are honored to support local organizations that possess deep knowledge, lived experience, and trusted relationships at the community level. By investing in their work, we're helping to accelerate progress toward stronger and more equitable health outcomes for all."

The inaugural grantees of the Healthy Futures Solution Fund are:

Stan McLaren, MBA
Chief Executive Officer, Boston Health Care for the Homeless Program
"This funding is an investment in the dignity and well-being of the people we serve. With Sanofi's support, we're able to expand access to integrated care for individuals experiencing homelessness — meeting them where they are and helping address both medical needs and social factors that impact their health."

The funding period runs through June 2026. At the end of the program, each organization plans to submit an impact report outlining measurable outcomes, learnings, and stories about how the grant affected their community.

About Sanofi
Sanofi is an R&D driven, AI-powered biopharma company committed to improving people's lives and delivering compelling growth. We apply our deep understanding of the immune system to invent medicines and vaccines that treat and protect millions of people around the world, with an innovative pipeline that could benefit millions more. Our team is guided by one purpose: we chase the miracles of science to improve people's lives; this inspires us to drive progress and deliver positive impact for our people and the communities we serve, by addressing the most urgent healthcare, environmental, and societal challenges of our time.

Sanofi is listed on EURONEXT: SAN and NASDAQ: SNY

Media Relations
Sandrine Guendoul | + 33 6 25 09 14 25 | sandrine.guendoul@sanofi.com
Evan Berland | +1 215 432 0234 | evan.berland@sanofi.com
Léo Le Bourhis | + 33 6 75 06 43 81 | leo.lebourhis@sanofi.com
Victor Rouault | + 33 6 70 93 71 40 | victor.rouault@sanofi.com
Timothy Gilbert | + 1 516 521 2929 | timothy.gilbert@sanofi.com
Léa Ubaldi | +33 6 30 19 66 46 | lea.ubaldi@sanofi.com

Investor Relations
Thomas Kudsk Larsen | + 44 7545 513 693 | thomas.larsen@sanofi.com  
Alizé Kaisserian | + 33 6 47 04 12 11 | alize.kaisserian@sanofi.com
Felix Lauscher | + 1 908 612 7239 | felix.lauscher@sanofi.com  
Keita Browne | + 1 781 249 1766 | keita.browne@sanofi.com
Nathalie Pham | + 33 7 85 93 30 17 | nathalie.pham@sanofi.com
Tarik Elgoutni | + 1 617 710 3587 | tarik.elgoutni@sanofi.com  
Thibaud Châtelet | + 33 6 80 80 89 90 | thibaud.chatelet@sanofi.com
Yun Li | +33 6 84 00 90 72 | yun.li3@sanofi.com

Cision View original content:https://www.prnewswire.com/news-releases/sanofi-awards-healthy-futures-solution-fund-grants-to-advance-community-led-solutions-expand-equitable-access-to-care-across-massachusetts-302491030.html

SOURCE Sanofi

Ausgewählte Hebelprodukte auf Sanofi

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Sanofi

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu Sanofi S.A.

Wer­bung

Analysen zu Sanofi S.A.

DatumRatingAnalyst
12.06.2025Sanofi BuyJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
05.06.2025Sanofi BuyJefferies & Company Inc.
04.06.2025Sanofi OutperformBernstein Research
03.06.2025Sanofi HoldDeutsche Bank AG
02.06.2025Sanofi OutperformBernstein Research
DatumRatingAnalyst
12.06.2025Sanofi BuyJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
05.06.2025Sanofi BuyJefferies & Company Inc.
04.06.2025Sanofi OutperformBernstein Research
02.06.2025Sanofi OutperformBernstein Research
02.06.2025Sanofi BuyUBS AG
DatumRatingAnalyst
03.06.2025Sanofi HoldDeutsche Bank AG
02.06.2025Sanofi NeutralJP Morgan Chase & Co.
02.06.2025Sanofi HoldDeutsche Bank AG
30.05.2025Sanofi NeutralJP Morgan Chase & Co.
08.05.2025Sanofi NeutralJP Morgan Chase & Co.
DatumRatingAnalyst
18.12.2024Sanofi SellDeutsche Bank AG
17.12.2024Sanofi SellDeutsche Bank AG
06.12.2024Sanofi SellDeutsche Bank AG
03.12.2024Sanofi SellDeutsche Bank AG
28.10.2024Sanofi SellDeutsche Bank AG

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Sanofi S.A. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen